Volato Group, Inc. (SOAR) recently announced a strategic investment of $2.2 million from Catheter Precision, marking a significant shift from its previous focus on critical minerals to artificial intelligence (AI) infrastructure. This decision follows the termination of a planned merger with M2i Global, which aimed to position Volato in the critical minerals sector. The investment, which involves restricted common stock, is intended to strengthen Volato's balance sheet and facilitate potential acquisitions in AI-related fields, including data infrastructure and power generation. Despite receiving two unsolicited non-binding letters of intent for AI-related deals, the company has not yet finalized any agreements. As a result of these developments, SOAR stock experienced a 23% drop in premarket trading. Retail investor sentiment remains optimistic, although the stock has fallen over 45% this year. Volato's CEO, Matt Liotta, expressed confidence that this pivot aligns better with the company's technology assets and long-term shareholder value aspirations.